Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution - Wikidata - wikimedia - TriplyDB

Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution

Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution

http://www.wikidata.org/entity/Q36633751

about

Renal replacement therapy in acute kidney injury: controversy and consensus Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid-base status and phosphate supplementation needs Ability of nafamostat mesilate to prolong filter patency during continuous renal replacement therapy in patients at high risk of bleeding: a randomized controlled study.Anticoagulation, delivered dose and outcomes in CRRT: The program to improve care in acute renal disease (PICARD).Regional citrate anticoagulation for RRTs in critically ill patients with AKI.Continuous venovenous haemofiltration with citrate-buffered replacement solution is safe and efficacious in patients with a bleeding tendency: a prospective observational study.Regional citrate anticoagulation in CVVH: a new protocol combining citrate solution with a phosphate-containing replacement fluid Efficacy and safety of a citrate-based protocol for sustained low-efficiency dialysis in AKI using standard dialysis equipment Citrate anticoagulation for continuous renal replacement therapy in small children.Year in review 2012: Critical Care--Nephrology.Heparin albumin priming in a clinical setting for hemodialysis patients at risk for bleeding.Severe acute kidney injury following cardiac surgery: short-term outcomes in patients undergoing continuous renal replacement therapy (CRRT).Citrate anticoagulation for CRRT in children: comparison with heparin.Safety and efficacy of regional citrate anticoagulation in continuous blood purification treatment of patients with multiple organ dysfunction syndrome.Regional citrate anticoagulation for renal replacement therapies in patients with acute kidney injury: a position statement of the Work Group "Renal Replacement Therapies in Critically Ill Patients" of the Italian Society of Nephrology.Safety and efficacy of citrate anti-coagulation continuous renal replacement therapies in post-cardiac surgery patients with liver dysfunction Renal replacement therapy in adult and pediatric intensive care : Recommendations by an expert panel from the French Intensive Care Society (SRLF) with the French Society of Anesthesia Intensive Care (SFAR) French Group for Pediatric Intensive Care E Regional citrate anticoagulation for pediatric CRRT using integrated citrate software and physiological sodium concentration solutions Anticoagulation strategies in venovenous hemodialysis in critically ill patients: a five-year evaluation in a surgical intensive care unit

P2860

Q26998864-75FC21E3-EE7B-409C-864D-472A70D24838 Q33587210-1D2A3FD8-FCB9-457B-993E-8F1A24B3088D Q34323157-ACDCDA26-66CA-4B0B-827A-F81FCDF4C68D Q34451757-58533C8C-9525-41C3-A99D-6C97E0E5BC76 Q34629661-F4F33815-0D35-4A03-BB69-C6C3F21DF939 Q34676665-40A20068-10B4-42B4-919E-8708310926AC Q36801142-5FEF96EF-E95D-4EF3-97A1-82985909EF99 Q37212336-57E420FD-67FA-40A5-84CC-9AF219878210 Q37554949-C467E41A-3897-4BFC-A994-D60DDBE2DE19 Q38165354-E43C88F9-5FF1-4267-B122-4B33D111962F Q39439383-5B38554C-36A3-4C7F-BCBF-25BDA3B65F4B Q41196531-F6909EC4-37A8-4EC8-A7D2-13BEDEB63A63 Q42086378-95DDA72E-8D13-4E22-AC5F-0543D4D674E8 Q46078253-37B3F77E-17C2-4FC3-98F7-FB6FF7216DB2 Q51018006-A8CC853E-2FA8-4C47-99C0-CC8422526FC1 Q56589994-A9FFD2DB-4C82-4421-9262-3971DC66A11B Q56967935-7415C3C0-9AF1-4287-8450-F8AF5A067D25 Q57764117-9A7B38DD-7F9A-4770-BD27-779AAACBCB04 Q59100879-43AAF904-D248-41F4-8640-7C1BB2241794

P2860

Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution

http://www.wikidata.org/entity/Q36633751

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Regional citrate anticoagulati ...... concentration citrate solution

@ast

Regional citrate anticoagulati ...... concentration citrate solution

@en

type

label

Regional citrate anticoagulati ...... concentration citrate solution

@ast

Regional citrate anticoagulati ...... concentration citrate solution

@en

prefLabel

Regional citrate anticoagulati ...... concentration citrate solution

@ast

Regional citrate anticoagulati ...... concentration citrate solution

@en

P1433

Q36633751-2AF4EE8A-CE59-4369-BE8D-1861B902A57C

P1476

Q36633751-86158F61-1E22-4A45-BC49-DBECCC65CA5A

P2093

Q36633751-129C7191-A8DF-46E3-BA7F-D8320F5B61E9

Q36633751-1A96DA9B-2CDD-4DE0-9958-7C936910D294

Q36633751-30FAF72D-A377-448A-A0D7-F1E55844D208

Q36633751-64FB1AC7-F100-4B15-B549-4B409271229B

Q36633751-7FE1EF04-2EC5-4A0F-9A1A-3E3887A73172

Q36633751-9E352641-7D4B-4B59-BE84-1A8DC1996423

Q36633751-C4B44FD9-8237-43D6-BCAF-E6970990000A

P2860

Q36633751-02EBE9F1-2C72-4888-ABB9-91B8EF47DF68

Q36633751-02EFE316-D17D-4723-A0A8-69D7ED1E370E

Q36633751-0E9B396F-D927-4017-8397-A9EC22824F26

Q36633751-1D91A264-9D62-48AA-96F0-00CB41363656

Q36633751-2197AF74-AF78-44B1-ADDF-48EC413BFD65

Q36633751-2B4D4C3D-C5AB-4393-8EE5-775AC4916CD3

Q36633751-324EC6FC-2733-43F2-B5B3-7263200F8AB7

Q36633751-3F9E1C1D-35FC-449A-8997-1779CE1C4229

Q36633751-4C73F38F-E671-45F5-9FE4-050D8DC934F2

Q36633751-4D8D7C7E-579E-45F2-A5F3-43D7E7F48383

P2888

Q36633751-71C89F0D-CF85-438F-8A6A-EAF6E49C2D3A

P304

Q36633751-7A129BFE-8AF0-4EDE-9196-7FB1C9A8C9C3

P31

Q36633751-3D7B6B44-3CFC-450E-A6B3-A4B62C3BF469

P356

Q36633751-B86F02D2-15D0-4D34-B87F-13D531E64DC8

P433

Q36633751-1098E962-45B4-4922-BF6C-D19636CB1C37

P478

Q36633751-E6BA86A6-5924-4FD0-AAC5-73E1F222E57B

P577

Q36633751-8806E0BE-A000-4092-941B-426DC4A98462

P5875

Q36633751-0F7B8DBD-8886-4439-B5FB-6335CF68E967

P6179

Q36633751-41E92FE2-FFE0-4D4D-A6F8-8F415F7098BA

P698

Q36633751-C2FD011B-B17C-44B1-855E-9676E3EA5201

P921

Q36633751-C8735D2A-9FF3-4F06-A120-F4CFC3CA51BC

P932

Q36633751-C66DA2DE-8401-45D9-837F-7FFA8000DBE3

P356

P1433

P1476

Regional citrate anticoagulati ...... concentration citrate solution

@en

P2093

Alessandro Pierucci

http://www.w3.org/2001/XMLSchema#string

Emanuela Strampelli

http://www.w3.org/2001/XMLSchema#string

Francesca Polistena

http://www.w3.org/2001/XMLSchema#string

Laura Zeppilli

http://www.w3.org/2001/XMLSchema#string

Luigi Tritapepe

http://www.w3.org/2001/XMLSchema#string

Santo Morabito

http://www.w3.org/2001/XMLSchema#string

Valentina Pistolesi

http://www.w3.org/2001/XMLSchema#string

P2860

Intensity of renal support in critically ill patients with acute kidney injury.

Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.

Citrate anticoagulation for continuous venovenous hemofiltration.

Regional anticoagulation with citrate is superior to systemic anticoagulation with heparin in critically ill patients undergoing continuous venovenous hemodiafiltration

Clinical review: anticoagulation for continuous renal replacement therapy--heparin or citrate?

Continuous venovenous hemofiltration with citrate-based replacement fluid: efficacy, safety, and impact on nutrition.

Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based?

Continuous renal replacement therapy: recent advances and future research.

Continuous renal replacement therapy: cause and treatment of electrolyte complications.

Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy.

P2888

P304

R111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/CC11403

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228080632

http://www.w3.org/2001/XMLSchema#string

P6179

1048538945

http://www.w3.org/2001/XMLSchema#string

P698

22738289

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

3580669

http://www.w3.org/2001/XMLSchema#string